
|Articles|September 23, 2015
Shaji Kumar on Treatment-Related Adverse Events From Monoclonal Antibodies
Author(s)Shaji Kumar
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
Advertisement
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
The main adverse event that is seen is infusion reactions, Kumar says. These reactions are easily managed and, even so, usually go away on their own.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Darzalex Faspro in High-Risk Smoldering Multiple Myeloma
2
Trodelvy Misses Primary Endpoint in ASCENT-07 Breast Cancer Trial
3
Myeloma Advocate Stresses Support for Caregivers in Black Community
4
Top Lung Cancer Stories from October: Insights, and Patient Journeys
5





